Dong Min, Yeh Felix, Tepp William H, Dean Camin, Johnson Eric A, Janz Roger, Chapman Edwin R
Howard Hughes Medical Institute and Department of Physiology, University of Wisconsin, Madison, WI 53706, USA.
Science. 2006 Apr 28;312(5773):592-6. doi: 10.1126/science.1123654. Epub 2006 Mar 16.
How the widely used botulinum neurotoxin A (BoNT/A) recognizes and enters neurons is poorly understood. We found that BoNT/A enters neurons by binding to the synaptic vesicle protein SV2 (isoforms A, B, and C). Fragments of SV2 that harbor the toxin interaction domain inhibited BoNT/A from binding to neurons. BoNT/A binding to SV2A and SV2B knockout hippocampal neurons was abolished and was restored by expressing SV2A, SV2B, or SV2C. Reduction of SV2 expression in PC12 and Neuro-2a cells also inhibited entry of BoNT/A, which could be restored by expressing SV2 isoforms. Finally, mice that lacked an SV2 isoform (SV2B) displayed reduced sensitivity to BoNT/A. Thus, SV2 acts as the protein receptor for BoNT/A.
广泛使用的A型肉毒杆菌神经毒素(BoNT/A)如何识别并进入神经元,目前尚不清楚。我们发现BoNT/A通过与突触囊泡蛋白SV2(A、B和C亚型)结合进入神经元。携带毒素相互作用结构域的SV2片段可抑制BoNT/A与神经元结合。BoNT/A与SV2A和SV2B基因敲除的海马神经元的结合被消除,而通过表达SV2A、SV2B或SV2C可恢复结合。PC12和Neuro-2a细胞中SV2表达的降低也抑制了BoNT/A的进入,通过表达SV2亚型可恢复。最后,缺乏一种SV2亚型(SV2B)的小鼠对BoNT/A的敏感性降低。因此,SV2作为BoNT/A的蛋白受体发挥作用。